A team of researchers from the US-based University of North Carolina has identified a potential treatment for a rare genetic disorder -- `Angelman syndrome`, a new study said on Monday.

Angelman syndrome is caused by mutations in the maternally inherited UBE3A gene and is characterised by poor muscle control, limited speech, epilepsy, and intellectual disabilities, explained researchers in the study published in the journal Nature Communications.